{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:16:52Z","timestamp":1754151412984,"version":"3.41.2"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,18]]},"DOI":"10.7759\/cureus.88250","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T19:02:54Z","timestamp":1752865374000},"source":"Crossref","is-referenced-by-count":0,"title":["Progression From Early Multiterritorial Punctate Infarcts to Massive Stroke in Fulminant Thrombotic Thrombocytopenic Purpura Despite Aggressive Therapy: A Therapeutic Dilemma in Initiating Antithrombotic Therapy"],"prefix":"10.7759","author":[{"given":"Zhuo","family":"Luan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13764","article-title":"Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics","volume":"15","author":"Saha M","year":"2017","unstructured":"Saha M, McDaniel JK, Zheng XL. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics. J Thromb Haemost. 2017, 15:1889-900. 10.1111\/jth.13764","journal-title":"J Thromb Haemost"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-02-791533","article-title":"The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis","volume":"132","author":"Masias C","year":"2018","unstructured":"Masias C, Cataland SR. The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis. Blood. 2018, 132:903-10. 10.1182\/blood-2018-02-791533","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.3807","article-title":"Immune thrombotic thrombocytopenic purpura: a review","author":"Pishko AM","year":"2025","unstructured":"Pishko AM, Li A, Cuker A. Immune thrombotic thrombocytopenic purpura: a review. JAMA. 2025, 10.1001\/jama.2025.3807","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly BS","year":"2017","unstructured":"Joly BS, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura. Blood. 2017, 129:2836-46. 10.1182\/blood-2016-10-709857","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2009.00710.x","article-title":"Fulminant plasmapheresis-refractory thrombotic microangiopathy associated with advanced gastric cancer","volume":"14","author":"Vasko R","year":"2010","unstructured":"Vasko R, Koziolek M, F\u00fczesi L, et al.. Fulminant plasmapheresis-refractory thrombotic microangiopathy associated with advanced gastric cancer. Ther Apher Dial. 2010, 14:222-5. 10.1111\/j.1744-9987.2009.00710.x","journal-title":"Ther Apher Dial"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031851","article-title":"Thrombotic thrombocytopenic purpura with neurological impairment: a review","volume":"101","author":"Zhu H","year":"2022","unstructured":"Zhu H, Liu JY. Thrombotic thrombocytopenic purpura with neurological impairment: a review. Medicine (Baltimore). 2022, 101:e31851. 10.1097\/MD.0000000000031851","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-221857","article-title":"Large vessel stroke as initial presentation of thrombotic thrombocytopenic purpura","volume":"2018","author":"Sugarman R","year":"2018","unstructured":"Sugarman R, Tufano AM, Liu JM. Large vessel stroke as initial presentation of thrombotic thrombocytopenic purpura. BMJ Case Rep. 2018, 2018:10.1136\/bcr-2017-221857","journal-title":"BMJ Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2024.109151","article-title":"Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura","volume":"243","author":"Truma A","year":"2024","unstructured":"Truma A, Mancini I, Agosti P, et al.. Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura. Thromb Res. 2024, 243:109151. 10.1016\/j.thromres.2024.109151","journal-title":"Thromb Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2025.06.002","article-title":"2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura","author":"Zheng XL","year":"2025","unstructured":"Zheng XL, Al-Housni Z, Cataland SR, et al.. 2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2025, 10.1016\/j.jtha.2025.06.002","journal-title":"J Thromb Haemost"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032327","article-title":"Safety of antiplatelet therapy in noncardioembolic ischemic stroke with thrombocytopenia: the CASE II study","volume":"13","author":"Xu D","year":"2024","unstructured":"Xu D, Zhou H, Zhang T, et al.. Safety of antiplatelet therapy in noncardioembolic ischemic stroke with thrombocytopenia: the CASE II study. J Am Heart Assoc. 2024, 13:e032327. 10.1161\/JAHA.123.032327","journal-title":"J Am Heart Assoc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7425320","article-title":"Atypical thrombotic thrombocytopenic purpura presenting as stroke","volume":"2019","author":"Badugu P","year":"2019","unstructured":"Badugu P, Idowu M. Atypical thrombotic thrombocytopenic purpura presenting as stroke. Case Rep Hematol. 2019, 2019:7425320. 10.1155\/2019\/7425320","journal-title":"Case Rep Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully M","year":"2019","unstructured":"Scully M, Cataland SR, Peyvandi F, et al.. Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura. N Engl J Med. 2019, 380:335-46. 10.1056\/NEJMoa1806311","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-551580","article-title":"How I treat refractory thrombotic thrombocytopenic purpura","volume":"125","author":"Sayani FA","year":"2015","unstructured":"Sayani FA, Abrams CS. How I treat refractory thrombotic thrombocytopenic purpura. Blood. 2015, 125:3860-7. 10.1182\/blood-2014-11-551580","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2022.100945","article-title":"Advances in the management of TTP","volume":"55","author":"Subhan M","year":"2022","unstructured":"Subhan M, Scully M. Advances in the management of TTP. Blood Rev. 2022, 55:100945. 10.1016\/j.blre.2022.100945","journal-title":"Blood Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-022-06549-z","article-title":"Large vessel stroke and isolated thrombocytopenia as presenting features of thrombotic thrombocytopenic purpura","volume":"44","author":"Romozzi M","year":"2023","unstructured":"Romozzi M, Vitali F, Marca GD, et al.. Large vessel stroke and isolated thrombocytopenia as presenting features of thrombotic thrombocytopenic purpura. Neurol Sci. 2023, 44:1461-3. 10.1007\/s10072-022-06549-z","journal-title":"Neurol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/392439-progression-from-early-multiterritorial-punctate-infarcts-to-massive-stroke-in-fulminant-thrombotic-thrombocytopenic-purpura-despite-aggressive-therapy-a-therapeutic-dilemma-in-initiating-antithrombotic-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T19:02:54Z","timestamp":1752865374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/392439-progression-from-early-multiterritorial-punctate-infarcts-to-massive-stroke-in-fulminant-thrombotic-thrombocytopenic-purpura-despite-aggressive-therapy-a-therapeutic-dilemma-in-initiating-antithrombotic-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.88250","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,18]]}}}